Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Achillion Pharma rises on results from study combining hepatitis C drugs ACH-3102 and Sovaldi
Achillion Pharma rises on results from study combining hepatitis C drugs ACH-3102 and Sovaldi
Achillion Pharma rises on results from study combining hepatitis C drugs ACH-3102 and Sovaldi
Submitted by
admin
on November 10, 2014 - 3:55pm
Source:
Yahoo/AP
News Tags:
Achillion
ACH-3102
hepatitis C
Sovaldi
Headline:
Achillion Pharma rises on results from study combining hepatitis C drugs ACH-3102 and Sovaldi
Do Not Allow Advertisers to Use My Personal information